Target intelligence / Profile preview

Free fatty acid receptor 2 (GPR43) (FFAR2)

Target
FFAR2
Molecular classification
G protein-coupled receptor
01

Overview

Free fatty acid receptor 2 (FFAR2), also known as GPR43, is a G protein-coupled receptor that serves as a primary sensor for short-chain fatty acids (SCFAs) such as acetate and propionate, which are metabolic byproducts of gut microbiota fermentation (UniProt P41145). FFAR2 is predominantly expressed on immune cells, including neutrophils and mast cells, where it acts as a critical link between microbial metabolism and the host immune system (Tan et al., 2014). Activation of FFAR2 by SCFAs has been shown to suppress mast cell degranulation and the subsequent release of inflammatory mediators like histamine and cytokines, thereby playing a protective role in allergic and inflammatory conditions (Folkerts et al., 2020). This receptor modulates intracellular signaling through Gi and Gq proteins, influencing chemotaxis and the production of reactive oxygen species. In disease contexts, the dysregulation of the SCFA-FFAR2 axis is associated with asthma, food allergies, and inflammatory bowel disease, making it a target of interest for therapeutic intervention. Drugs targeting FFAR2, including small molecule agonists and antagonists, are being explored for their potential to treat these immune-mediated disorders by restoring homeostatic immune signaling.

Other names
G-protein coupled receptor 43GPR43FFA2RFree fatty acid receptor 2
02

Mechanism of action

Agonism of the receptor by short-chain fatty acids (SCFAs) leads to the activation of Gi and Gq signaling pathways, which modulates immune cell activity and inhibits the release of pro-inflammatory mediators from mast cells.

03

Biological functions

Signal transductionImmune responseMetabolic regulationChemotaxis
04

Disease associations

InflammationAsthmaAllergyInflammatory bowel diseaseMetabolic syndrome
05

Safety considerations

Potential for systemic immune suppressionGastrointestinal side effectsContext-dependent pro-inflammatory effects
06

Interacting drugs

GLPG0974

4 more in the full profile.

07

Biomarkers

Fecal short-chain fatty acid levelsPlasma short-chain fatty acid levelsMast cell tryptaseFFAR2 expression levels

Beyond the preview

Go deeper on Free fatty acid receptor 2 (GPR43) (FFAR2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Free fatty acid receptor 2 (GPR43) (FFAR2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call